Tectonic Therapeutic (TECX) Stock Forecast & Price Target

$18.65

+0.18 (+0.97%)

(As of 09/17/2024 ET)

Tectonic Therapeutic - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 5 Analyst Ratings

Based on 5 Wall Street analysts who have issued ratings for Tectonic Therapeutic in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 4 have given a buy rating, and 1 has given a strong buy rating for TECX.

Consensus Price Target

$60.00
221.72% Upside

High Forecast	$76.00
Average Forecast	$60.00
Low Forecast	$49.00

According to the 5 analysts' twelve-month price targets for Tectonic Therapeutic, the average price target is $60.00. The highest price target for TECX is $76.00, while the lowest price target for TECX is $49.00. The average price target represents a forecasted upside of 221.72% from the current price of $18.65.

Type	Current Forecast 9/18/23 to 9/17/24	1 Month Ago 8/19/23 to 8/18/24	3 Months Ago 6/20/23 to 6/19/24	1 Year Ago 9/18/22 to 9/18/23
Consensus Rating	Buy	Buy	N/A	N/A
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A	N/A
Buy	4 Buy rating(s)	3 Buy rating(s)	N/A	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	N/A	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	N/A	N/A
Consensus Price Target	$60.00	$62.50	N/A	N/A
Forecasted Upside	221.72% Upside	279.25% Upside	N/A	N/A

Central Bank Abandons USD (Ad)

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

TECX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TECX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tectonic Therapeutic Stock vs. The Competition

Type	Tectonic Therapeutic	Medical Companies	S&P 500
Consensus Rating Score	3.20	2.77	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	221.72% Upside	1,008.89% Upside	7.65% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/22/2024	Wells Fargo & Company 3 of 5 stars	T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$55.00	+238.46%
7/24/2024	Leerink Partnrs 0 of 5 stars	D. Risinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/24/2024	Leerink Partners 1 of 5 stars		Initiated Coverage	Outperform	$49.00	+188.40%
6/26/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Rahimi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$76.00	+375.89%
6/24/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:43 PM ET.

TECX Forecast - Frequently Asked Questions

What is Tectonic Therapeutic's forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Tectonic Therapeutic is $60.00, with a high forecast of $76.00 and a low forecast of $49.00.
Should I buy or sell Tectonic Therapeutic stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tectonic Therapeutic in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TECX shares.
Does Tectonic Therapeutic's stock price have much upside?: According to analysts, Tectonic Therapeutic's stock has a predicted upside of 265.78% based on their 12-month stock forecasts.
Has Tectonic Therapeutic been upgraded by Wall Street analysts recently?: Over the previous 90 days, Tectonic Therapeutic's stock had 1 upgrade by analysts.
What analysts cover Tectonic Therapeutic?: Tectonic Therapeutic has been rated by research analysts at Leerink Partners, Leerink Partnrs, Piper Sandler, TD Cowen, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Tectonic Therapeutic more than its competitors?: Analysts like Tectonic Therapeutic more than other "medical" companies. The consensus rating for Tectonic Therapeutic is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TECX compares to other companies.